Publication | Closed Access
A Randomized, Double‐Blind, Placebo‐Controlled Study of Botulinum Toxin Type A for the Treatment of Glabellar Lines
127
Citations
13
References
2007
Year
Reloxin (Dysport/botulinum toxin type A) treatment resulted in a significant improvement in glabellar lines, and the 50-U dose was identified as optimal. All doses were well tolerated.
| Year | Citations | |
|---|---|---|
Page 1
Page 1